NEWS

News

2020

11-May

Hummingbird Bioscience closes US$25M investment with Series B extension

SINGAPORE, May 11, 2020 -- Hummingbird Biosciences, a Heritas Venture Fund-backed company, has closed an extended Series B funding round of US$25 million. This brings the total capital raised through financing activities and strategic partnerships to more than US$65 million to date

More information at: https://www.hummingbirdbioscience.com/en/news-events/hummingbird-bioscience-series-b-extension/